Febuxostat Tablet
Product Images NDC 27808-207

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 27808-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tris Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Febuxostat Structure (Febuxostat Tablets 1)

Chemical structure of febuxostat, showing its molecular arrangement including a thiazole ring, various aromatic rings, and functional groups, along with a notation indicating 1/2 molecule of water (hydrate form).*

FDA Label Image

40 mg (30 count)

Label for Febuxostat Tablets 40 mg, oral dosage form, packaged as 30 tablets. The label includes storage instructions, manufacturer Indoco Remedies Ltd., and distributor Tris Pharma Inc. It displays NDC 27808-206-01 and a notice for pharmacists to dispense the Medication Guide to patients.*

FDA Label Image

80 mg (30 Tablets)

Label for Febuxostat Tablets 80 mg oral tablets in a 30 tablet package by Tris Pharma Inc. The label includes NDC 27808-207-01, manufacturer Indoco Remedies Ltd India, and storage instructions to protect from light and store controlled room temperature. The label also advises pharmacists to dispense the enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.